191 related articles for article (PubMed ID: 2217208)
1. Promoter deletion and loss of retinoblastoma gene expression in human prostate carcinoma.
Bookstein R; Rio P; Madreperla SA; Hong F; Allred C; Grizzle WE; Lee WH
Proc Natl Acad Sci U S A; 1990 Oct; 87(19):7762-6. PubMed ID: 2217208
[TBL] [Abstract][Full Text] [Related]
2. Analysis of retinoblastoma (RB) gene deletion in human prostatic carcinomas.
Sarkar FH; Sakr W; Li YW; Macoska J; Ball DE; Crissman JD
Prostate; 1992; 21(2):145-52. PubMed ID: 1329054
[TBL] [Abstract][Full Text] [Related]
3. Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated RB gene.
Bookstein R; Shew JY; Chen PL; Scully P; Lee WH
Science; 1990 Feb; 247(4943):712-5. PubMed ID: 2300823
[TBL] [Abstract][Full Text] [Related]
4. The molecular basis of cancer suppression by the retinoblastoma gene.
Lee WH
Princess Takamatsu Symp; 1989; 20():159-70. PubMed ID: 2488231
[TBL] [Abstract][Full Text] [Related]
5. Inactivation of the retinoblastoma gene in human bladder and renal cell carcinomas.
Ishikawa J; Xu HJ; Hu SX; Yandell DW; Maeda S; Kamidono S; Benedict WF; Takahashi R
Cancer Res; 1991 Oct; 51(20):5736-43. PubMed ID: 1913692
[TBL] [Abstract][Full Text] [Related]
6. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB
Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
[TBL] [Abstract][Full Text] [Related]
7. Deletions of chromosome 13q, mutations in Retinoblastoma 1, and retinoblastoma protein state in human hepatocellular carcinoma.
Zhang X; Xu HJ; Murakami Y; Sachse R; Yashima K; Hirohashi S; Hu SX; Benedict WF; Sekiya T
Cancer Res; 1994 Aug; 54(15):4177-82. PubMed ID: 8033150
[TBL] [Abstract][Full Text] [Related]
8. Alterations of the retinoblastoma gene in human prostate adenocarcinoma.
Tricoli JV; Gumerlock PH; Yao JL; Chi SG; D'Souza SA; Nestok BR; deVere White RW
Genes Chromosomes Cancer; 1996 Feb; 15(2):108-14. PubMed ID: 8834174
[TBL] [Abstract][Full Text] [Related]
9. Inactivation of the retinoblastoma susceptibility gene in non-small-cell lung cancer. The Lung Cancer Study Group.
Reissmann PT; Koga H; Takahashi R; Figlin RA; Holmes EC; Piantadosi S; Cordon-Cardo C; Slamon DJ
Oncogene; 1993 Jul; 8(7):1913-9. PubMed ID: 8390038
[TBL] [Abstract][Full Text] [Related]
10. C-terminal truncation of the retinoblastoma gene product leads to functional inactivation.
Shew JY; Lin BT; Chen PL; Tseng BY; Yang-Feng TL; Lee WH
Proc Natl Acad Sci U S A; 1990 Jan; 87(1):6-10. PubMed ID: 1688660
[TBL] [Abstract][Full Text] [Related]
11. Disruption of Rb/E2F pathway results in increased cyclooxygenase-2 expression and activity in prostate epithelial cells.
Davis JN; McCabe MT; Hayward SW; Park JM; Day ML
Cancer Res; 2005 May; 65(9):3633-42. PubMed ID: 15867358
[TBL] [Abstract][Full Text] [Related]
12. Retinoblastoma gene mutations in primary human prostate cancer.
Kubota Y; Fujinami K; Uemura H; Dobashi Y; Miyamoto H; Iwasaki Y; Kitamura H; Shuin T
Prostate; 1995 Dec; 27(6):314-20. PubMed ID: 7501543
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical expression of retinoblastoma and p53 tumor suppressor genes in prostatic intraepithelial neoplasia: comparison with prostatic adenocarcinoma and benign prostate.
Tamboli P; Amin MB; Xu HJ; Linden MD
Mod Pathol; 1998 Mar; 11(3):247-52. PubMed ID: 9521470
[TBL] [Abstract][Full Text] [Related]
14. Structure of the human retinoblastoma gene.
Hong FD; Huang HJ; To H; Young LJ; Oro A; Bookstein R; Lee EY; Lee WH
Proc Natl Acad Sci U S A; 1989 Jul; 86(14):5502-6. PubMed ID: 2748600
[TBL] [Abstract][Full Text] [Related]
15. Altered messenger RNA and unique mutational profiles of p53 and Rb in human esophageal carcinomas.
Huang Y; Meltzer SJ; Yin J; Tong Y; Chang EH; Srivastava S; McDaniel T; Boynton RF; Zou ZQ
Cancer Res; 1993 Apr; 53(8):1889-94. PubMed ID: 8467510
[TBL] [Abstract][Full Text] [Related]
16. Frequent inactivation of the retinoblastoma anti-oncogene is restricted to a subset of human tumor cells.
Horowitz JM; Park SH; Bogenmann E; Cheng JC; Yandell DW; Kaye FJ; Minna JD; Dryja TP; Weinberg RA
Proc Natl Acad Sci U S A; 1990 Apr; 87(7):2775-9. PubMed ID: 2181449
[TBL] [Abstract][Full Text] [Related]
17. Variable mutations of the RB gene in small-cell lung carcinoma.
Mori N; Yokota J; Akiyama T; Sameshima Y; Okamoto A; Mizoguchi H; Toyoshima K; Sugimura T; Terada M
Oncogene; 1990 Nov; 5(11):1713-7. PubMed ID: 2176283
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanism of retinoblastoma gene inactivation in retinoblastoma cell line Y79.
Lee EY; Bookstein R; Young LJ; Lin CJ; Rosenfeld MG; Lee WH
Proc Natl Acad Sci U S A; 1988 Aug; 85(16):6017-21. PubMed ID: 3413073
[TBL] [Abstract][Full Text] [Related]
19. The retinoblastoma protein regulates hypoxia-inducible genetic programs, tumor cell invasiveness and neuroendocrine differentiation in prostate cancer cells.
Labrecque MP; Takhar MK; Nason R; Santacruz S; Tam KJ; Massah S; Haegert A; Bell RH; Altamirano-Dimas M; Collins CC; Lee FJ; Prefontaine GG; Cox ME; Beischlag TV
Oncotarget; 2016 Apr; 7(17):24284-302. PubMed ID: 27015368
[TBL] [Abstract][Full Text] [Related]
20. Rb loss is characteristic of prostatic small cell neuroendocrine carcinoma.
Tan HL; Sood A; Rahimi HA; Wang W; Gupta N; Hicks J; Mosier S; Gocke CD; Epstein JI; Netto GJ; Liu W; Isaacs WB; De Marzo AM; Lotan TL
Clin Cancer Res; 2014 Feb; 20(4):890-903. PubMed ID: 24323898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
